Brodsky & Smith investigates fiduciary duty breaches in four major merger deals.

Brodsky & Smith LLC has announced investigations into whether the boards of Esperion Therapeutics, Sila Realty Trust, Lisata Therapeutics, and SkyWater Technology breached their fiduciary duties to shareholders during recent merger agreements. The investigations focus on whether these boards conducted fair processes and offered fair value to shareholders in the deals. These mergers involve cash and stock transactions with values ranging from $3.16 to $35 per share. Investors holding shares in these companies are encouraged to contact Brodsky & Smith for more information, with no cost or obligation involved.